Insider Shareholders with Direct Ownership of Aeglea Bio Therapeutics, Inc. (AGLE)
This section provides a comprehensive overview of the insiders with direct ownership of Aeglea Bio Therapeutics, Inc. (AGLE). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Aeglea BioTherapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 2,310,924 | 135,610 | 2,175,314 $60.2 Million | 6 |
May 11, 2018
Reduced 0.89%
|
|
|
Cameron Turtle
Chief Executive Officer |
723,840 | 0 | 746,907 $20.7 Million | 2 |
Feb 15, 2024
Added 0.05%
|
|
Anthony G. Quinn
President & CEO |
278,379 | 0 | 550,540 $15.2 Million | 6 |
Mar 16, 2022
Added 12.7%
|
|
Jonathan Alspaugh
President and CFO |
165,372 | 0 | 165,372 $4.57 Million | 5 |
Mar 11, 2022
Added 31.2%
|
|
Armen Shanafelt
Director |
150,000 | 0 | 150,000 $4.15 Million | 3 |
Dec 13, 2021
Added 8.92%
|
|
Scott L Burrows
Chief Financial Officer |
134,953 | 18,531 | 116,422 $3.22 Million | 2 |
Sep 03, 2024
Reduced 13.73%
|
|
Marcio Souza
Director |
90,000 | 0 | 90,000 $2.49 Million | 1 |
Aug 25, 2022
Added 50.0%
|
|
Jr. Michael Conick Hanley
Chief Business Officer |
28,200 | 0 | 36,200 $1 Million | 1 |
Jun 08, 2022
Added 43.79%
|